Anticonvulsant effects of magnesium sulfate on hippocampal seizures

Therapeutic implications in preeclampsia-eclampsia

D. B. Cotton, C. A. Janusz, Robert F Berman

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objective: The objective of this study was to determine whether magnesium sulfate has central anticonvulsant effects. Study design: In three experiments we investigated the anticonvulsant properties of magnesium sulfate on the hippocampus because of its high density of N-methyl-D-aspartate receptors and link to clinical epilepsy. Seizure activity was elicited in the hippocampus of rats or in in vitro hippocampal brain slices. The effects of magnesium on seizure activity were determined. Results: (1) Intraperitoneal magnesium sulfate (270 or 360 mg/kg) failed to block hippocampal seizures but reduced electroencephalographic amplitude and seizure duration. (2) Injection of magnesium sulfate directly into a seizure focus blocked seizures and elevated seizure thresholds. (3) Low magnesium levels produced epileptiform activity in an in vitro hippocampal brain slice preparation; the epileptiform activity was reversed by increasing the magnesium concentration. Conclusions: Magnesium sulfate has central anticonvulsant activity on hippocampal seizures, implicating the N-methyl-D-aspartate receptor in eclamptic seizures and in the therapeutic efficacy of magnesium sulfate.

Original languageEnglish (US)
Pages (from-to)1127-1136
Number of pages10
JournalAmerican Journal of Obstetrics and Gynecology
Volume166
Issue number4
StatePublished - 1992
Externally publishedYes

Fingerprint

Magnesium Sulfate
Eclampsia
Pre-Eclampsia
Anticonvulsants
Seizures
Magnesium
Therapeutics
N-Methyl-D-Aspartate Receptors
Hippocampus
Brain
Epilepsy
Injections

Keywords

  • eclampsia
  • hippocampus
  • magnesium sulfate
  • seizures

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Anticonvulsant effects of magnesium sulfate on hippocampal seizures : Therapeutic implications in preeclampsia-eclampsia. / Cotton, D. B.; Janusz, C. A.; Berman, Robert F.

In: American Journal of Obstetrics and Gynecology, Vol. 166, No. 4, 1992, p. 1127-1136.

Research output: Contribution to journalArticle

@article{fdc7b1d3b922401b9d023ced717e37d6,
title = "Anticonvulsant effects of magnesium sulfate on hippocampal seizures: Therapeutic implications in preeclampsia-eclampsia",
abstract = "Objective: The objective of this study was to determine whether magnesium sulfate has central anticonvulsant effects. Study design: In three experiments we investigated the anticonvulsant properties of magnesium sulfate on the hippocampus because of its high density of N-methyl-D-aspartate receptors and link to clinical epilepsy. Seizure activity was elicited in the hippocampus of rats or in in vitro hippocampal brain slices. The effects of magnesium on seizure activity were determined. Results: (1) Intraperitoneal magnesium sulfate (270 or 360 mg/kg) failed to block hippocampal seizures but reduced electroencephalographic amplitude and seizure duration. (2) Injection of magnesium sulfate directly into a seizure focus blocked seizures and elevated seizure thresholds. (3) Low magnesium levels produced epileptiform activity in an in vitro hippocampal brain slice preparation; the epileptiform activity was reversed by increasing the magnesium concentration. Conclusions: Magnesium sulfate has central anticonvulsant activity on hippocampal seizures, implicating the N-methyl-D-aspartate receptor in eclamptic seizures and in the therapeutic efficacy of magnesium sulfate.",
keywords = "eclampsia, hippocampus, magnesium sulfate, seizures",
author = "Cotton, {D. B.} and Janusz, {C. A.} and Berman, {Robert F}",
year = "1992",
language = "English (US)",
volume = "166",
pages = "1127--1136",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Anticonvulsant effects of magnesium sulfate on hippocampal seizures

T2 - Therapeutic implications in preeclampsia-eclampsia

AU - Cotton, D. B.

AU - Janusz, C. A.

AU - Berman, Robert F

PY - 1992

Y1 - 1992

N2 - Objective: The objective of this study was to determine whether magnesium sulfate has central anticonvulsant effects. Study design: In three experiments we investigated the anticonvulsant properties of magnesium sulfate on the hippocampus because of its high density of N-methyl-D-aspartate receptors and link to clinical epilepsy. Seizure activity was elicited in the hippocampus of rats or in in vitro hippocampal brain slices. The effects of magnesium on seizure activity were determined. Results: (1) Intraperitoneal magnesium sulfate (270 or 360 mg/kg) failed to block hippocampal seizures but reduced electroencephalographic amplitude and seizure duration. (2) Injection of magnesium sulfate directly into a seizure focus blocked seizures and elevated seizure thresholds. (3) Low magnesium levels produced epileptiform activity in an in vitro hippocampal brain slice preparation; the epileptiform activity was reversed by increasing the magnesium concentration. Conclusions: Magnesium sulfate has central anticonvulsant activity on hippocampal seizures, implicating the N-methyl-D-aspartate receptor in eclamptic seizures and in the therapeutic efficacy of magnesium sulfate.

AB - Objective: The objective of this study was to determine whether magnesium sulfate has central anticonvulsant effects. Study design: In three experiments we investigated the anticonvulsant properties of magnesium sulfate on the hippocampus because of its high density of N-methyl-D-aspartate receptors and link to clinical epilepsy. Seizure activity was elicited in the hippocampus of rats or in in vitro hippocampal brain slices. The effects of magnesium on seizure activity were determined. Results: (1) Intraperitoneal magnesium sulfate (270 or 360 mg/kg) failed to block hippocampal seizures but reduced electroencephalographic amplitude and seizure duration. (2) Injection of magnesium sulfate directly into a seizure focus blocked seizures and elevated seizure thresholds. (3) Low magnesium levels produced epileptiform activity in an in vitro hippocampal brain slice preparation; the epileptiform activity was reversed by increasing the magnesium concentration. Conclusions: Magnesium sulfate has central anticonvulsant activity on hippocampal seizures, implicating the N-methyl-D-aspartate receptor in eclamptic seizures and in the therapeutic efficacy of magnesium sulfate.

KW - eclampsia

KW - hippocampus

KW - magnesium sulfate

KW - seizures

UR - http://www.scopus.com/inward/record.url?scp=0026523072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026523072&partnerID=8YFLogxK

M3 - Article

VL - 166

SP - 1127

EP - 1136

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -